Suppr超能文献

伴有肿瘤血栓的肾细胞癌在癌症演变和肿瘤微环境中的时空异质性。

Spatio-temporal heterogeneity in cancer evolution and tumor microenvironment of renal cell carcinoma with tumor thrombus.

作者信息

Zhou Sian, Zheng Junhua, Zhai Wei, Chen Yonghui

机构信息

Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.

Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China; Department of Urology, State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.

出版信息

Cancer Lett. 2023 Sep 28;572:216350. doi: 10.1016/j.canlet.2023.216350. Epub 2023 Aug 12.

Abstract

Metastasis is the most fatal aspect of cancer, often preceded by a tumor thrombus (TT) which forms within the vascular system. Renal cell carcinoma (RCC), the predominant form of kidney cancer, witnesses a venous system invasion in 4-10% of cases, resulting in venous tumor thrombus (RCC-TT). This variant represents a formidable clinical challenge due to its escalated surgical complexity, heightened risk of progression and metastasis, and an adverse prognosis. However, recent trials addressing RCC-TT face significant barriers stemming from the profound inter- and intra-tumoral heterogeneity, patient-specific treatment variations, and distinct therapeutic resistance patterns between the primary tumor (PT) and the TT. This review delves into the unique evolutionary pathway of RCC-TT, the relationship between the staging and grading of RCC-TT invasion patterns, and the spatial molecular profiling of RCC-TT. Additionally, we assess the temporal heterogeneity among TT, PT, and distant metastases, as well as the functional phenotypes of TME components. An outlook for future research on RCC-TT is also provided.

摘要

转移是癌症最致命的方面,通常之前会形成血管系统内的肿瘤血栓(TT)。肾细胞癌(RCC)是肾癌的主要形式,4%至10%的病例会出现静脉系统侵犯,导致静脉肿瘤血栓(RCC-TT)。由于手术复杂性增加、进展和转移风险升高以及预后不良,这种变体代表了一项严峻的临床挑战。然而,最近针对RCC-TT的试验面临重大障碍,这些障碍源于肿瘤间和肿瘤内的深刻异质性、患者特异性治疗差异以及原发性肿瘤(PT)和TT之间不同的治疗耐药模式。本综述深入探讨了RCC-TT独特的进化途径、RCC-TT侵袭模式的分期与分级之间的关系以及RCC-TT的空间分子图谱。此外,我们评估了TT、PT和远处转移之间的时间异质性,以及肿瘤微环境成分的功能表型。还提供了RCC-TT未来研究的展望。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验